← Leaderboards
Marjorie Robert-Guroff
University Of Washington
$2,142,617
Attributed
$2,142,617
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $868.3K · FY2005–09$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$2,142,617 · 6
By mechanism
P51$2,142,617 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Juan Bonifacino$3,443
- Dmitry Shayakhmetov$15,184,716
- Farhood Farjah$5,283,632
- Andre Michael Lieber$20,253,196
- Shiu-Lok Hu$65,602,557
Others in their field
Top investigators on “Recombinants”
- David Heimbrook · Leidos Biomedical Research, Inc.$147,165,789
- Barton F Haynes · Duke University$134,153,827
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Stanley B Prusiner · University Of California San Francisco$55,441,768
- Thomas William Geisbert · Boston University Medical Campus$50,907,172
- Larry Arthur$46,063,806
Research focus
RecombinantsVaccinesVaccine DevelopmentMacaca MulattaHiv VaccineDesignProtective EfficacyEnv Gene ProductsAdenovirusesAntibodiesFutureBaseTransmission ProcessMacacaImmunityInfectionGenesRectalClinicTranslationsCellsBloodResponseMediating
Grant awards (45)
Development of a Vaccine for HIV-AIDS: Translation to the Clinic$1,030,346
ZIA · FY2020 · CA · contact PI
Development of a Vaccine for HIV-AIDS: Cellular Immunity$343,449
ZIA · FY2020 · CA · contact PI
Development of a Vaccine for HIV-AIDS: Humoral Immunity$343,449
ZIA · FY2020 · CA · contact PI
Development of a Vaccine for HIV-AIDS: Translation to the Clinic$1,675,208
ZIA · FY2019 · CA · contact PI
Development of a Vaccine for HIV-AIDS: Cellular Immunity$1,005,124
ZIA · FY2019 · CA · contact PI
Development of a Vaccine for HIV-AIDS: Humoral Immunity$670,082
ZIA · FY2019 · CA · contact PI
Development of a Vaccine for HIV-AIDS: Humoral Immunity$1,664,829
ZIA · FY2018 · CA · contact PI
Development of a Vaccine for HIV-AIDS: Cellular Immunity$998,897
ZIA · FY2018 · CA · contact PI
Development of a Vaccine for HIV-AIDS: Translation to the Clinic$665,931
ZIA · FY2018 · CA · contact PI
Development of a Vaccine for HIV-AIDS: Humoral Immunity$3,148,210
ZIA · FY2016 · CA · contact PI
Development of a Vaccine for HIV-AIDS: Translation to the Clinic$393,526
ZIA · FY2016 · CA · contact PI
Development of a Vaccine for HIV-AIDS: Cellular Immunity$393,526
ZIA · FY2016 · CA · contact PI
Development of a Vaccine for HIVAIDS: Humoral Immunity$2,718,739
ZIA · FY2015 · CA · contact PI
Development of a Vaccine for HIVAIDS: Translation to the Clinic$339,843
ZIA · FY2015 · CA · contact PI
Development of a Vaccine for HIVAIDS: Cellular Immunity$339,843
ZIA · FY2015 · CA · contact PI
Development of a Vaccine for HIVAIDS: Humoral Immunity$2,666,567
ZIA · FY2014 · CA · contact PI
Development of a Vaccine for HIVAIDS: Cellular Immunity$761,876
ZIA · FY2014 · CA · contact PI
Development of a Vaccine for HIVAIDS: Translation to the Clinic$380,938
ZIA · FY2014 · CA · contact PI
Development of a Vaccine for HIVAIDS: Humoral Immunity$2,279,616
ZIA · FY2013 · CA · contact PI
Development of a Vaccine for HIVAIDS: Cellular Immunity$1,139,808
ZIA · FY2013 · CA · contact PI
Development of a Vaccine for HIVAIDS: Translation to the Clinic$379,936
ZIA · FY2013 · CA · contact PI
Development of a Vaccine for HIVAIDS: Cellular Immunity$1,792,105
ZIA · FY2012 · CA · contact PI
Development of a Vaccine for HIVAIDS: Humoral Immunity$1,792,105
ZIA · FY2012 · CA · contact PI
Development of a Vaccine for HIVAIDS: Translation to the Clinic$398,245
ZIA · FY2012 · CA · contact PI
Development of a Vaccine for HIVAIDS: Cellular Immunity$1,696,890
ZIA · FY2011 · CA · contact PI
Development of a Vaccine for HIVAIDS: Humoral Immunity$1,696,890
ZIA · FY2011 · CA · contact PI
Development of a Vaccine for HIVAIDS: Translation to the Clinic$377,087
ZIA · FY2011 · CA · contact PI
Development of a Vaccine for HIVAIDS: Humoral Immunity$1,789,624
ZIA · FY2010 · CA · contact PI
Development of a Vaccine for HIVAIDS: Cellular Immunity$1,789,624
ZIA · FY2010 · CA · contact PI
Development of a Vaccine for HIVAIDS: Translation to the Clinic$397,694
ZIA · FY2010 · CA · contact PI
Development of a Vaccine for HIVAIDS: Humoral Immunity$1,783,832
ZIA · FY2009 · CA · contact PI
Development of a Vaccine for HIVAIDS: Cellular Immunity$1,783,832
ZIA · FY2009 · CA · contact PI
VACCINE USING HIV/SIV ENV, GAG, NEF & TAT ADENOVIRUS WITH PROTEIN BOOSTING$497,090
P51 · FY2009 · RR · contact PI
Development of a Vaccine for HIVAIDS: Translation to the Clinic$396,407
ZIA · FY2009 · CA · contact PI
Development of a Vaccine for HIVAIDS: Cellular Immunity$1,266,575
Z01 · FY2008 · CA · contact PI
Development of a Vaccine for HIVAIDS: Humoral Immunity$1,266,575
Z01 · FY2008 · CA · contact PI
VACCINE USING HIV/SIV ENV, GAG, NEF & TAT ADENOVIRUS WITH PROTEIN BOOSTING$371,459
P51 · FY2008 · RR · contact PI
Development of a Vaccine for HIVAIDS: Translation to the Clinic$281,461
Z01 · FY2008 · CA · contact PI
Basic and Applied Studies in Development of an AIDS Vaccine$4,139,375
Z01 · FY2007 · CA · contact PI
VACCINE COMPARISON OF HIV/SIV WITH PROTEIN BOOSTING IN RHESUS MACAQUES$434,134
P51 · FY2007 · RR · contact PI
VACCINE USING HIV/SIV ENV, GAG, NEF & TAT ADENOVIRUS WITH PROTEIN BOOSTING$434,134
P51 · FY2007 · RR · contact PI
VACCINE USING HIV/SIV ENV, GAG, NEF & TAT ADENOVIRUS WITH PROTEIN BOOSTING$228,467
P51 · FY2006 · RR · contact PI
Basic and Applied Studies in Development of an AIDS Vacc$0
Z01 · FY2006 · BC · contact PI
VACCINE USING HIV/SIV ENV, GAG, , NEF AND TAT ADENOVIRUS RECOMBINANTS$177,333
P51 · FY2005 · RR
Basic and Applied Studies in Development of an AIDS Vacc$0
Z01 · FY2005 · BC